{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for valproic root_modifications_structuralModifications_molecularFragment_refPname in root_modifications_structuralModifications_molecularFragment_refPname (approximate match)
Status:
Investigational
Source:
INN:temtokibart [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Source:
INN:opugotamig olatansine [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:anivovetmab [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:pamlectabart [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Source:
INN:acrixolimab [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:utreglutide [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:colulintide [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03769506: Phase 3 Interventional Active, not recruiting Head and Neck Cancer
(2019)
Source URL:
Class:
PROTEIN